(1S,3R)-3-((tert-butoxycarbonyl)amino)cyclohexanecarboxylic acid, 95.0%, 100g

(3-((2-Cyanoethyl)carbamoyl)phenyl)boronic acid, 98%, 1g

(S)-3-Phenyl-2-(pyrazine-2-carboxamido)propanoic acid, 95.0%, 100g

TLC separation chamber, 1 Piece(s)

1,3,5-Tribromoadamantane, 95.0%, 1g

1-(4-Methyl-piperazin-1-ylmethyl)-propylamine, 95.0%, 1g

TCO-PEG4-NHS ester, 250mg

2-AMINO-5-IODOPYRIDINE-3-CARBOXALDEHYDE, 95%, 5g

Dicyclohexyl(3-isopropoxy-2',4',6'-triisopropyl-[1,1'-biphenyl]-2-yl)phosphine, 98%, 1g

(R)-1,3'-Bipyrrolidine, 95.0%, 1g

N-benzyl-1-methyl-1H-pyrazol-3-amine, 95%, 500mg

(6-Methylpyridazin-3-yl)methanol, 95.0%, 250mg

4-Hydroxyphthalic acid, 98.0%, 25g